Total IP	19
Total IP Rank #	78,339
IP Activity Score	2.3/5.0    28
IP Activity Rank #	28,073
Dominant Nice Class	Scientific, technological and in...

Patents Trademarks 10 1 3 1 3 1 0
Last Patent	2024 - Crystalline chloro-n-(4-(morphol...
First Patent	2021 - P38alpha mitogen-activated prote...
Last Trademark	2023 - GEN1E LIFESCIENCES
First Trademark	2023 - GEN1E LIFESCIENCES

Industry (Nice Classification)

Latest Inventions, Goods, Services 2024 Invention Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride salt. Cr... Invention Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors. Substituted naphthyl ... Invention P38alpha mitogen-activated protein kinase inhibitors. Disclosed herein are p38α mitogen-activate... 2023 G/S Artificial intelligence powered novel drug development services. G/S Artificial intelligence powered novel drug development services. G/S Artificial intelligence powered novel pharmaceutical drug development services 2022 Invention Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors. Substituted naphthyl p... Invention P38α mitogen-activated protein kinase inhibitors. Disclosed herein are p38α mitogen-activated pro... Invention Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochl... Invention Substituted naphthyl p38α mitogen-activated protein kinase inhibitors. Substituted naphthyl p38α ... 2021 Invention Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl) naphthalene-1-sulfonamide di-hydroch... Invention N-(4-(morpholinomethyl)phenyl) naphthalene-1-sulfonamide di-hydrochloride di-hydrate. NN-(4-(morp... Invention P38alpha mitogen-activated protein kinase inhibitors. Disclosed herein are p38a mitogen-activated...